Background. -Quantitative assessment of primary mitral regurgitation (MR) using left ventricular (LV) volumes obtained with three-dimensional transthoracic echocardiography (3D TTE) recently showed encouraging results. Nevertheless, 3D TTE is not incorporated into everyday practice, as current LV chamber quantification software products are time consuming. Aims. -To investigate the accuracy and reproducibility of new automated fast 3D TTE software (HeartModel A.I. ; Philips Healthcare, Andover, MA, USA) for the quantification of LV volumes and MR severity in patients with isolated degenerative primary MR; and to compare regurgitant volume (RV) obtained with 3D TTE with a cardiac magnetic resonance (CMR) reference.
Background
Accurate quantification of primary mitral regurgitation (MR) is essential for clinical decision-making regarding surgery [1] . Current guidelines propose integration of qualitative, semiquantitative and quantitative criteria for grading the severity of MR [1, 2] . Two-dimensional (2D) transthoracic echocardiography (TTE) is the first-line method for the assessment of MR severity. Cardiac magnetic resonance (CMR), using a combination of left ventricular (LV) volumetric measurements and aortic flow quantification with phase-contrast velocity mapping [3] , has emerged as a reproducible and accurate alternative method for quantifying MR. Discrepant grading in MR severity between 2D TTE and CMR was reported recently [4] . The proximal isovelocity surface area (PISA) method is currently the main quantitative method for MR grading, but shows some reproducibility issues in routine clinical practice [5] . Other quantitative tools to assess MR severity have been proposed. Mitral regurgitant volume (RV) can be calculated as the difference between total LV stroke volume obtained by echocardiography and Doppler LV forward flow. Despite promising landmark reports using 2D TTE [6, 7] , this method has not received wide acceptance in clinical practice, as quantification of LV volumes by 2D TTE is frequently flawed by significant variability, foreshortening and reliance upon geometric models. Three-dimensional (3D) echocardiography does not rely on geometric assumptions for volume calculations, and is not subject to plane positioning errors [8] . Compared with CMR, which is the gold standard for cardiac chamber quantification, LV volumes calculated from 3D TTE showed significantly smaller bias and lower intraand interobserver variability than 2D TTE [8] . Quantitative assessment of primary mitral MR regurgitation using LV volumes obtained with 3D TTE recently showed encouraging results [9] . Nevertheless, time-consuming workflow and the need for 3D expertise have limited integration of 3D quantification into clinical practice [10] . Recently, initial validation of new automated 3D TTE software has shown good accuracy and reproducibility, with promising time saving [10] .
Thus, the aims of this prospective study were to investigate the accuracy and reproducibility of new automated fast 3D TTE software (HeartModel A.I. ; Philips Healthcare, Andover, MA, USA) for the quantification of LV volumes and MR RV in patients with isolated degenerative primary MR, and to compare RVs obtained with the PISA method and 3D TTE with a CMR reference.
Methods
The study was conducted in two centres (Monaco Heart Centre, Monaco; and Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France). Over a 12-month period, 62 patients with at least isolated mild primary MR, and having comprehensive 3D TTE and CMR studies, were eligible for inclusion. Exclusion criteria were: more than mild aortic stenosis, aortic regurgitation or mitral stenosis; intracardiac shunt; standard contraindications to magnetic resonance imaging; and poor TTE image quality. Institutional review board approval was obtained before conducting the study. The study was conducted in accordance with institutional policies, national legislation and the revised Helsinki declaration.
Echocardiography
All patients underwent comprehensive 2D and 3D transthoracic echocardiographic studies, using a commerciallyavailable ultrasound system (EPIQ 7C; Philips Healthcare). For transthoracic evaluation of the mitral valve, the Carpentier nomenclature was applied to the mitral valve leaflets (anterior leaflet A1, A2 and A3 = lateral, middle and medial scallops, respectively; posterior leaflet P1, P2 and P3 = lateral, middle and medial scallops, respectively). The anterolateral commissures and posteromedial commissures were also inserted in the 2D TTE examination.
Quantitative Doppler assessment of MR
Echocardiographic data for MR grading were acquired according to a standardized protocol with multiple 2D incidences. PISA radius was measured in midsystole, in either apical or parasternal views, as appropriate, with the lower Nyquist limit set to 30-40 cm/s and zoomed in on the area of flow convergence. Mitral RV (RV PISA) was calculated using the PISA technique as previously described [1] , and RV PISA was categorized as recommended by the American Heart Association/American College of Cardiology [11] : mild, <30 mL; mild to moderate, 30-44 mL; moderate to severe, 45-59 mL; and severe, ≥60 mL.
Quantitative volumetric assessment of MR
3D volumes were acquired with an X5-1 matrix array transducer (5-1 MHz), from the standard apical four-chamber window, with the patient in the left lateral decubitus position. The left ventricle and left atrium were centred along the volume axis by adjusting depth and sector. Sector width was adjusted and narrowed to increase the frame rates of the volume. Special care was taken to ensure optimal gain and compression, to minimize dropout of the LV myocardial borders. Novel acquisition mode allowed fast acquisition of full-volume data sets, with a high volume rate. Multiple consecutive cardiac beats could be acquired during a single breath-hold.
All 3D volumes were obtained in digital format, and stored for analysis by dedicated automated quantification software (HeartModel). This new commercially-available software is a unique model-based segmentation algorithm using knowledge-based identification followed by patientspecific adaptation [10] . After initiating the programme, the software automatically identifies heart chambers, and determines the end-diastolic and end-systolic frames using motion analysis. The software then automatically builds end-diastolic and end-systolic 3D volumes. As recommended by the vendor, the HeartModel 80-40 was chosen as the ''standard'' default setting value for 3D TTE study. The software then reveals a display of 2D views (apical two-, three-and four-chamber views) from a 3D volume, and allows global and regional editing of the end-diastolic volume (EDV) and end-systolic volume (ESV) borders. Volume borders could be edited regionally or globally by moving the entire border when the user was not fully satisfied with the automated LV contour [12] . 3D LV total stroke volume was obtained using the difference between HeartModel EDV and ESV. LV forward stroke volume was calculated as the product of the LV outflow tract (LVOT) velocity-time integral and the LVOT cross-sectional area. To obtain the cross-sectional area, the LVOT diameter was measured from inner edge to inner edge using a magnified image, with depth and focus set to optimize visualization of the LVOT perpendicular to the ultrasound beam, and allowing clear visualization of the basal insertion points of the aortic leaflets. The LVOT velocity-time integral was obtained classically from an apical five-chamber view using pulse-wave Doppler. Mitral RV HeartModel was obtained off-line by measuring the difference in LV total stroke volume (obtained from 3D HeartModel acquisition) and aortic forward stroke volume.
CMR technique
All patients underwent comprehensive TTE and CMR studies within 24 h, in similar haemodynamic states. Patients were imaged with a 3-Tesla Skyra scanner (Siemens, Erlangen, Germany), with 18-channel body flex coils and 45 mT/m gradients, or a 3-Tesla Discovery TM 750w (GE Healthcare, Chicago, IL, USA), equipped with a 24-channel torso phased-array coil for signal reception. Assessment of cardiac function was performed with a cine steady-state free precession pulse sequence, with retrospective gating, in end-expiration breath-hold. The following projections were acquired: two-chamber, four-chamber and parallel contiguous short axis (to cover the entire LV from the mitral plane to the apex). CMR data were processed offline using dedicated software, with semiautomatic edge detection and manual correction of the endocardial contour by an experienced independent observer blinded to the results of the TTE. On the cine images, LV ejection fraction, EDV and ESV were calculated using the standard formula. Data were analysed by dedicated software: cvi 42 ® , version 5.1 (Circle Cardiovascular Imaging, Calgary, AB, Canada) or ADW cardiacVX (GE Healthcare). Aortic phase contrast was performed 10 mm above the tip of the aortic valve, perpendicular to the aorta. Aortic outflow volume was derived from quantitative flow measurements. Regurgitant volume (RV CMR) was calculated as the difference between LV total stroke volume obtained from CMR acquisition and aortic forward flow volume (obtained from phase contrast analysis). RV CMR was categorized using American Heart Association/American College of Cardiology guidelines [11] : mild, <30 mL; mild to moderate, 30-44 mL; moderate to severe, 45-59 mL; and severe, ≥60 mL.
Statistical analysis
Data for study population and TTE and CMR measurements are presented as numbers and percentages or means ± standard deviations after testing for normal distribution (Kolmogorov-Smirnov test). CMR and TTE measurements were compared by Student's paired t tests or Wilcoxon rank tests, as appropriate. Correlation and agreement between CMR and TTE measurements were assessed by Pearson's correlations, intraclass correlation coefficients (ICCs) and Bland-Altman comparisons. Test-retest and inter-and intraobserver variability were examined for 3D TTE measurements in a group of 16 patients selected at random. For interobserver variability, measurements were performed in all patients by one observer, then repeated offline on two separate days by two independent observers who were blinded to each other's measurements and the study time point. For intraobserver variability, one observer analysed the data twice (analyses undertaken 1 week apart), and was blinded to the data from the first read. For test-retest reproducibility, a first 3D volume was obtained, then, after repositioning of the patient and the transducer, a second 3D volume was acquired by a different observer. Variability data are presented as concordance correlation coefficients and as coefficients of variation (COVs). All statistical analyses were performed using commercially-available software (MedCalc, version 16.8; MedCalc Software, Mariakerke, Belgium). All P values are the result of two-tailed tests. A value of P < 0.05 was considered significant.
Results

Study population and feasibility
Nine patients (14%) were excluded because of insufficient echogenicity in 3D TTE. Thus, the final study group consisted of 53 patients (37 men; mean age 64 ± 12 years). The baseline demographic and clinical characteristics of the 53 patients are displayed in Table 1 . The average 3D volume rate was good (20 ± 2 Hz, range 15-25 Hz), even in patients with 3D TTE LV volumes >200 mL (n = 16; 19 ± 2 Hz, range 15-22 Hz). Data are expressed as mean ± standard deviation or number (%). 2D: two-dimensional; CMR: cardiac magnetic resonance; LVEF: left ventricular ejection fraction; MR: mitral regurgitation; PISA: proximal isovelocity surface area. 
Reproducibility of 3D TTE measurements
Using HeartModel, intraobserver variabilities for EDV and ESV were excellent (r = 0.96, COV = 4% and r = 0.95, COV = 4%, respectively; all P < 0.0001) ( Fig. 1) . Interobserver variabilities for EDV and ESV were r = 0.78, COV = 9% and r = 0.79, COV = 10%, respectively (all P < 0.0001). Test-retest variabilities for EDV and ESV were r = 0.97, COV = 5% and r = 0.96, COV = 7%, respectively (all P < 0.0001).
Comparison of 3D TTE LV volumes with CMR
EDV obtained by the different methods was 203 ± 62 mL by CMR and 191 ± 53 mL by HeartModel (P = 0.0001) ( Table 2) . Despite systematic underestimation of EDV with Heart-Model compared with CMR (bias = −12 ± 22 mL), a significant correlation was found between the two measurements (r = 0.93; P < 0.0001) ( Fig. 2A and Table 3 ). ESV obtained by the different methods was 76 ± 33 mL by CMR and 70 ± 31 mL by HeartModel (P = 0.03). Despite systematic underestimation of ESV with HeartModel compared with CMR (bias = −6 ± 20 mL), a significant correlation was found between the measurements (r = 0.81; P < 0.0001) ( Fig. 2B and Table 3 ). LV ejection fraction was similar between CMR and HeartModel (63 ± 9% vs 64 ± 8%, respectively; P = 0.31). A significant correlation was found between the two measurements (r = 0.81; P < 0.0001), with good agreement (bias = 0.8 ± 5.5%) ( Fig. 2C and Table 3 ).
Concordance between echocardiography and CMR
RV was 57 ± 23 mL by CMR, 69 ± 30 mL by the PISA method (P = 0.0001 with CMR) and 56 ± 28 mL by HeartModel (P = 0.22 with CMR) ( Table 2 and Fig. 3 ).
There was significant overestimation of RV using the PISA method compared with CMR (bias = 12 ± 21 mL), and a moderate correlation was found between the two measurements (r = 0.70; P < 0.0001) ( Fig. 4 and Table 3 ). Individual data for RV determined by the different methods according to the MR grade determined by RV CMR are presented in Fig. 5 . A contingency table of RV CMR and RV PISA assessment of MR severity is shown in Table 4 . There was complete agreement in only 34 of 53 patients (64%). Concordance was good between the two modalities (ICC = 0.78; 95% confidence interval [CI] 0.63-0.88; P < 0.0001). If patients were categorized into four grades (mild, mild to moderate, moderate to severe and severe MR), concordance between PISA and CMR grading was good (ICC = 0.82; 95% CI 0.68-0.90; P < 0.0001). None of the patients with mild MR using RV PISA grading had severe MR on CMR. When considering patients with severe MR using RV PISA grading, only 19/33 (61%) had concordant severe MR on CMR. RV HeartModel was similar compared with CMR (bias = −2 ± 12 mL), and a substantial correlation was found between the two measurements (r = 0.89; P < 0.0001) ( Fig. 4 and Table 3 ). A contingency table of RV CMR and RV HeartModel assessment of MR severity is shown in Table 5 . There was complete agreement in 43 of 53 patients (81%). Concordance was good between the two modalities (ICC = 0.89; 95% CI 0.81-0.94; P < 0.0001). If patients were categorized into four grades (mild, mild to moderate, moderate to severe and severe MR), concordance between HeartModel and CMR grading was excellent (ICC = 0.90; 95% CI 0.83-0.94; P < 0.0001). None of the patients with mild MR using RV HeartModel grading had severe MR on CMR. When considering patients with severe MR using RV HeartModel grading, 18/21 (86%) had concordant severe MR on CMR.
Comparison between mid-late systolic MR and holosystolic MR showed no significant difference in effective regurgitant orifice area and RV obtained by CMR, the PISA method or HeartModel (Table 6 ). Using a CMR reference, mid-late systolic MR was more frequently moderate (9/13; 69%) than severe (4/13; 31%). In patients with mid-late systolic MR, MR severity was more frequently overestimated by RV PISA compared with RV HeartModel (3/13; 23% vs 1/13; 8%, respectively) compared with a CMR reference. The bias between RV PISA and RV CMR was similar between holosystolic and mid-late systolic MR (12.6 ± 23 mL vs 10.6 ± 19 mL, respectively). Overestimation of RV HeartModel compared with RV CMR tended to be more important in mid-late systolic MR than in holosystolic MR (bias 6 ± 12 mL vs 1 ± 12 mL, respectively).
Discussion
This study shows that 3D TTE using the new generation of automated software is a reproducible and accurate imaging modality for the assessment of MR RV using LV volumes in patients with isolated degenerative primary MR, compared with CMR.
Echocardiography is the first-line modality for the assessment of MR severity, providing numerous variables derived mainly from Doppler imaging. Recently, considerable controversy has arisen regarding discordance between TTE and CMR in assessing MR severity [4] . Quantitative comparison of MR severity using RV obtained with both modalities revealed only modest correlation. Alternative echocardiographic quantitative methods to assess RV using volumetric calculation have been proposed. Despite promising reports using 2D TTE [7] , this method has not received wide acceptance in clinical practice, as 2D TTE is subject to underestimation of LV volumes because of foreshortening or assumptions about LV shape. 3D echocardiography does not rely on geometric assumptions for volume calculations, 0  3  2  3  8  Severe  0  5  9  19  33  Total  6  12  13  22  53 Data are expressed as number. CMR: cardiac magnetic resonance; PISA: proximal isovelocity surface area. 0  6  3  4  13  Severe  0  0  3  18  21  Total  6  12  13  22  53 Data are expressed as number. CMR: cardiac magnetic resonance. and is not subject to plane positioning errors [8] . Compared with CMR, which is the gold standard for cardiac chamber quantification, LV volumes calculated from 3D TTE showed significantly smaller bias and lower intra-and interobserver variability than 2D TTE [8, 13] . We found excellent 3D TTE reproducibility using HeartModel, with low interand intraobserver variability and a COV ≤ 10% for all variables, which is consistent with previous data [10, 12, 14, 15] . This new automated application uses knowledge-based identification of LV chambers followed by patient-specific adaptation [10] . This reliable automated detection of heart chambers does not need user input, which improves the consistency of measurements and reduces the time required for analysis [10] . Using this new software, LV volumes (EDV, ESV and stroke volume) appeared to be well correlated with CMR (r = 0.93, r = 0.81 and r = 0.83, respectively; all P < 0.0001), with clinically acceptable bias (−12 ± 22 mL, −6 ± 20 mL and −5 ± 22 mL, respectively). Accurate and reliable assessment of LV volume and LV remodelling is a key point in MR. Ideally, longitudinal follow-up of patients with MR will involve multiple imaging modalities. Nevertheless, CMR suffers from several limitations [16] , such as limited availability, local expertise or the presence of cardiac pacemakers and implantable cardioverter-defibrillators. 3D TTE using new-generation automated software may offer a reliable and accurate surrogate imaging modality for LV volume quantification and remodelling in routine practice. A recent study [9] reported encouraging results for the quantitative assessment of primary MR using LV volumes obtained with 3D TTE, showing accurate discrimination of patients with severe MR, defined using a multivariable integrative approach, as recommended [1] . In clinical practice, the PISA method is currently the main echocardiographic method for RV estimation. CMR assessment of RV is a different approach, derived from volumetric calculation, which may explain modest correlations reported between RV obtained with these two modalities. CMR-derived RV appears to be systematically lower than RV obtained with echocardiography, particularly compared with the PISA method [4, [17] [18] [19] [20] [21] . Our study confirms this tendency, as RV CMR was, on average, 12 ± 21 mL lower than RV PISA, comparable with previous results [21] . This overestimation of RV by the PISA method may lead to discordance in grading between CMR and echocardiography [4] . Using a volumetric 3D TTE approach, we found excellent correlations and low bias between 3D TTE-and CMR-derived RV estimations. Such concordance in MR severity assessment may occur because the methods are based on the same physical principles, relying on volumetric estimation. Complete agreement with CMR grading was also more frequent with 3D TTE than with the PISA method (76% vs 63%). This may be because of more frequent overestimation of MR severity with the PISA method than with 3D TTE in case of mid-late systolic MR (23% vs 8% in our series). Multiple assumptions, eccentric jet direction and phasic variation of PISA may explain this overestimation. On the other hand, there are no uniform CMR thresholds for grading severity of regurgitation [22] . Because of the paucity of data, the general cut-offs for RV recommended by echocardiography and American College of Cardiology/American Heart Association guidelines are used [22] . Nevertheless, a recent study [21] reported that CMR-derived RVs associated with severe primary MR (39 mL) were lower than established cut-offs values based on echocardiography.
Study limitations
We did not use ultrasound contrast agent in any patient in this study, which could have improved the feasibility of 3D TTE. Nevertheless, our study provides insight into real-life echocardiographic practice, and the performance of the 3D software with echocardiographic contrast agents is unknown [10] . Echocardiographic MR grading was based on RV estimation in our study, rather than on an integrative approach, as we aimed to compare each echocardiographic method with a CMR reference. Quantification of RV using a volumetric method can only be achieved in patients with isolated MR. However, most adults have significant regurgitation of only a single valve, making this approach clinically applicable in most cases. Pulsed Doppler estimation of RV was not performed systematically.
In the present study, we did not specifically study patients in whom the shape of flow convergence region was not optimal, as the PISA method is known to overestimate RV in this setting. Another limitation is cardiac arrhythmia. Nevertheless, recent data suggest that 3D TTE remains reliable in atrial fibrillation, provided that averaged values of LV volumes are measured during multiple consecutive beats [14] . As this study was done in routine practice, we did not record the time required for all 3D analyses in all patients. Previous studies specifically showed a reduction in the duration of examination using this software [10] . The correlation between RV HeartModel, symptoms and outcome deserves further research.
Conclusions
3D TTE RV assessment using a new generation of automated software correlates well with CMR in patients with isolated degenerative primary MR.
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